Ready-to-Use Therapeutic Food Market

High Demand for Drinkable Therapeutic Foods

Formulations which can be ingested in a liquid form are slated to emerge as the most prominent category of ready-to-use therapeutic foods. Since a majority of the malnourished population cluster falls in the below 5 years’ age group, sales of drinkable foods is surging.

Infants do not yet have a fully developed digestive system. Therefore, they require formulae which are easy to break down and absorbed by the bloodstream. Therapeutic foods in liquid form help achieve this objective. A staggering double-digit CAGR is predicted for the drinkable therapeutic foods segment.

The UNICEF Effort

The United Nations Children’s Fund (UNICEF) has always been at the forefront of combating hunger and malnutrition associated with the global paediatric population. Various awareness campaigns and relief programs have been established by this organization in the recent past.

To achieve its objective, UNICEF has established various therapeutic feeding centres to save lives and support families in some of the poorest regions of the world, such as the Central African Republic. The organization is slated to remain the primary buyer of ready-to-use therapeutic food market through 2030.

Demand Growing Outside of Traditional Markets

The Middle East & Africa region is slated to generate potential green spaces for ready-to-use therapeutic food manufacturers. Many African countries have high levels of malnutrition, and efforts to mitigate through pragmatic options are underway.

Several NGOs such as UNICEF and WFP as well as various government organizations are augmenting their presence in countries such as Kenya, Malawi, Nigeria and Ethiopia, some of the world’s poorest countries. The region is slated to register a substantially high CAGR throughout the forecast period.

COVID-19 Impact on Ready-to-Use Therapeutic Food Market

The COVID-19 pandemic has amplified the risk of acute malnutrition among the poorest sections of the society. In the face of government-mandated shutdowns, millions of people have become unemployed, especially in the agriculture sector, thus disrupting critical nutrition enhancement programs.

The impact has been especially drastic across the developing and underdeveloped worlds. It is apprehended that severely malnourished children are at a dangerously high risk of contracting the novel coronavirus due to weakened immunity. The same is true for the geriatric population.

Hence, manufacturers are implementing several arrangements to ensure that the availability of ready-to-use therapeutic foods is not hampered. As a result, sales have largely been sustained throughout the course of the pandemic, and is expected to remain so in the future.

Leading Ready-to-Use Therapeutic Food Market Players

Some prominent players operating within the ready-to-use therapeutic food landscape include:

• Nuflower Foods
• GC Rieber Compact AS
• Valid Nutrition
• InnoFaso
• Edesia Inc.
• Nutrivita Foods
• Diva Nutritional Products
• Insta Products Ltd.
• Mana Nutritive Aid Product Inc.
• Meds & Food for Kids Inc.
• Samil Industrial Co.
• Tabatchnick Fine Foods Inc.
• Amul India
• Hilina Enriched Foods PLC
• Société de Transformation Alimentaire

The aforementioned market players are actively involved in developing and launching new nutrition enhancing formulations in various forms. In addition, these players are collaborating with governmental and non-governmental agencies to aid in effective distribution of ready-to-use therapeutic foods to the most severely impacted regions.

Ready-to-Use Therapeutic Food Market- Report Scope

Key questions answered in the report

• Briefly outline the growth of ready-to-use therapeutic food market.

  The global ready-to-use therapeutic food market is anticipated to register a double digit CAGR, crossing the US$ 300 Mn mark by 2020-end.

• Which is the most popular ready-to-use therapeutic food?

  According to FMI’s analysis, the drinkable foods segments is poised to experience maximum sales. Growth is underpinned by high incidence of infant malnutrition. Also, liquid supplements are easier to digest by young babies.

• How will COVID-19 impact the market?

  The COVID-19 pandemic has resulted in a major spike in ready-to-use therapeutic food products consumption. High degree of susceptibility to the infection due an already weakened immune system is expected to generate high demand therapeutic foods.

• Which region is expected to be the most promising in the future?

  The Middle East & Africa is slated to be a revenue hotspot, attributed to a high incidence of poverty and hunger which has ultimately ushered in high levels of malnutrition.

• Identify the key players operating in the market.

  Some prominent players operating within the ready-to-use therapeutic food landscape include:

• Nuflower Foods
• GC Rieber Compact AS
• Valid Nutrition
• InnoFaso
• Edesia Inc.
• Nutrivita Foods
• Diva Nutritional Products

  These players are actively involved in developing and launching new nutrition enhancing formulations in various forms. In addition, these players are collaborating with governmental and non-governmental agencies to aid in effective distribution of ready-to-use therapeutic foods to the most severely impacted regions.

Enquiry before Buying

• Is this research conducted by Future Market Insights?

  Yes, the ready-to-use therapeutic food market research has been conducted by expert analysts of Future Market Insights through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to the research analyst

• What research methodology is followed by FMI?

  FMI follows a methodology that encompasses the demand side assessment of the market, and triangulates the same through a supply side analysis. This methodology is based on use of standard market structure, methods and definitions.

• Who are the respondents for primary research?

  FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. For a full list of primary respondents, please reach out to us.

• What are the sources of secondary research?

  FMI conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request. 

• Is a sample of this report available for evaluation?

  Yes, you can request a sample and it will be sent to you through an email.

• How can I buy this report?

  FMI provides a secure online payment system to buy report seamlessly. You can buy the report securely and safely.

Key Segment

Type

• Solid
• Paste
• Drinkable Therapeutic Food

End User

• UNICEF
• WFP
• NGOs
• Others

Region

• North America (U.S & Canada)
• Latin America (Brazil, Mexico & Rest of Latin America)
• Europe (France, Germany, Spain, U.K, Italy, BENELUX, Nordics, Russia, Poland & Rest of Europe)
• Asia Pacific (China, India, Japan, ASEAN, Australia & New Zealand and Rest of APAC)
• Middle East & Africa (GCC, North Africa, Tanzania, Ethiopia, Nigeria, Malawi, Kenya, South Africa & Rest of MEA)